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Our approach is motivated by two considerations. First, an LMM with no fixed effects using genetic similarities constructed from a set of SNPs is mathematically equivalent to a linear regression of the SNPs on the phenotype (with weights integrated over independent normal distributions having the same variance-in particular, the genetic variance) 3 . That is, an LMM using a given set of SNPs for genetic similarity is equivalent to (Bayesian) linear regression using those SNPs as covariates to correct for confounding. In theory, this equivalence holds only for certain forms of genetic similarity matrices, such as the realized relationship matrix 2, 3 . In practice, however, the realized relationship matrix and other measures of similarity, such as identity by state 1 , yield very similar measures of association (Supplementary Note 1) , and thus our demonstration is quite general.
Second, regardless of the form of regression used for GWAS, the significance of SNP-phenotype association should be determined by conditioning on exactly those SNPs that are associated with the phenotype. These SNPs include causal SNPs, or those nearby that tag causal SNPs, and SNPs that are associated by way of confounding (for example, because of population structure). By conditioning on causal or tagging SNPs, we reduce the noise in the assessment of the association 4 . By conditioning on SNPs associated because of confounding, we control for such confounding 5 . Moreover, if a SNP is unrelated to the phenotype, it should not be in the conditioning set. In the particular case in which we use Bayesian linear regression for GWAS, the inclusion of unrelated SNPs in the genetic similarity matrix decreases the relative influence of each SNP on the phenotype (because all SNP weights share the same prior distribution whose variance-the genetic variance in the LMM view-is estimated from the data). The decrease in influence leads to incomplete correction for confounding and hence inflated test statistics and reduced power. We refer to this phenomenon as 'dilution. ' To identify SNPs that satisfy these principles, we developed a simple heuristic that yields improved power and calibration. First, we order SNPs by their linear-regression P values from lowest to highest. Then we construct genetic similarity matrices with an increasing number of SNPs as previously ordered until we find the first minimum in l GC (the genomic control factor). In practice, the number of SNPs selected is typically smaller than the number of individuals analyzed, a condition that can be exploited by an existing algorithm, FaST-LMM, to yield large computational savings 2 .
The equivalence between the LMM and Bayesian linear regression also implies that, when a given SNP is being tested, that SNP should be excluded from the computation of genetic similarity to avoid using it as a covariate. Including the SNP would make the log likelihood of the null model higher than it should be and lead to deflation of the test statistic and loss of power. We call this phenomenon 'proximal contamination' . In addition to the SNP being tested, we also exclude those SNPs in close proximity (for example, within 2 centimorgans), as linkage disequilibrium will lead to a similar deflation and loss of power. A naive algorithm for excluding these from the similarity matrix is computationally expensive, so we developed a speedup (Supplementary Note 2) . Together, the linear-regression scan to select SNPs for inclusion in the matrix and Supplementary Table 4). Many proteins were either overrepresented or underrepresented in each of the protease data sets, and clustering showed that enzyme specificity had the most influence on the results. Some examples within the top 1,000 proteins showed that for specific proteins, one protease outperformed all the others (Fig. 1c and Supplementary Fig. 3 ). Our data demonstrated that quantitation based on both spectral counting and peptide intensity was indeed biased when solely relying on a single protease, and this bias affected even the most abundant proteins, sometimes by more than a factor of 1,000. Amino acid analysis revealed that proteins overrepresented in a data set obtained by a particular protease contained relatively more cleavage-specific residues for that protease (Supplementary Fig. 3 ). Our data stresses that the best proteotypic peptides are not necessarily tryptic, a finding that may affect other quantitative assays such as selected reaction monitoring as well.
Raw and processed mass spectrometry identification data are available through thegpm.org at ftp://ftp.proteomecentral.org/ public/0/ice.0.e.
Improved linear mixed models for genome-wide association studies
To the Editor: The use of linear mixed models (LMMs) in genomewide association studies (GWAS) is now widely accepted 1 because LMMs have been shown to be capable of correcting for several forms of confounding due to genetic relatedness, such as population structure and familial relatedness 1 , and because recent advances have made them computationally efficient 1,2 . LMMs tackle confounding by using a matrix of pairwise genetic similarities to model the relatedness among subjects. The consensus until now has been that all available single-nucleotide polymorphisms (SNPs) should be used along with the efficient removal of the test SNPs and those nearby constitute our new approach, FaST-LMM-Select.
When applied to Wellcome Trust data for Crohn's disease 6 ( Table 1 , Supplementary Fig. 1, Supplementary Table 1 and Supplementary Methods) that includes family members and non-Caucasians, FaST-LMM-Select yielded slightly less inflation, fewer false positives and fewer false negatives (due to lack of dilution) compared to the use of all SNPs while accounting for proximal contamination. When all SNPs were used, proximal contamination had a dramatic effect on calibration and false positives even though correction for it excluded (on average) only 516 of the available 356,441 SNPs from the genetic similarity matrix. Compared with the original version of FaST-LMM, wherein equally spaced SNPs were used to reduce computational demands, FaST-LMM-Select had far better calibration and fewer false positives. FaST-LMM-Select also performed well on synthetic data (Supplementary Note 1) and other real cohorts with substantial genetic structure (Supplementary Note 3) .
FaST-LMM-Select is available at http://mscompbio.codeplex.com/.
